Is Fatigue a Side Effect of Wegovy — and What Should You Do About It?

Why Wegovy can leave you feeling drained

Semaglutide slows gastric emptying and reduces appetite by acting on GLP-1 receptors in the gut and brain. Both effects are useful for weight management, but they also carry side consequences. Eating noticeably less means your total energy intake drops, sometimes faster than your body is fully prepared for. At the same time, nausea (which affects a significant proportion of people starting treatment) can itself cause tiredness. Add a dose increase to the mix and the system is adapting to several changes at once.

The NHS semaglutide medicines page lists tiredness among the common side effects (those affecting up to one in ten people) alongside nausea, diarrhoea, constipation and headache. The pattern is consistent: symptoms tend to cluster around the start of a new dose level and diminish over days to a couple of weeks as tolerance builds. That cycle repeats with each upward step on the titration schedule.

For a more detailed look at how this particular effect develops over the course of treatment, our guide to Wegovy and fatigue walks through the mechanism and the timeline in plain language. Understanding what your body is doing makes it easier to tell the difference between an expected adjustment period and something that needs attention.

Factors that make the fatigue worse, and practical things that help

A few things amplify tiredness during the early weeks. Poor hydration is probably the biggest: GI symptoms (loose stools, vomiting) can quietly deplete fluid levels without you realising, and even mild dehydration hits energy hard. Low protein intake matters too. When overall food consumption falls sharply, protein is often the first thing squeezed out, and muscle tissue needs adequate protein to stay intact and functional.

Sleep quality sometimes dips early in treatment, partly because nausea and reflux can disturb rest. If heartburn is part of the picture, our page on heartburn as a Wegovy side effect covers what tends to help. Gentle activity (even a short walk) often supports energy better than complete rest, though pushing hard through the first weeks is rarely a good idea.

Practical things worth trying: drinking enough water throughout the day (not just at meals), keeping protein at roughly a quarter of what you eat, not skipping meals entirely even when appetite is low, and giving yourself permission to sleep more than usual for the first fortnight. These are supportive measures, not substitutes for speaking to your prescriber if things are not improving.

There is also a broader picture worth naming: the relationship between semaglutide and fatigue is an active area of patient experience. It is not a reason to stop; for most people the energy returns and they continue treatment without difficulty.

When tiredness on Wegovy means you should get medical help

Most fatigue on Wegovy is self-limiting. Some is not, and the difference matters.

Get urgent help if tiredness arrives alongside severe, persistent stomach pain that spreads to the back, with or without vomiting. This pattern can indicate pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. It is rare, but it needs to be ruled out quickly.

Contact a GP or 111 promptly if you notice: yellowing of the skin or whites of the eyes (a sign of gallbladder or liver problems), extreme dizziness or near-fainting, difficulty breathing, or a racing heartbeat. Severe dehydration from persistent vomiting or diarrhoea can also cause exhaustion that is disproportionate to what you would expect, that needs assessment rather than waiting. The full side-effect overview for Wegovy covers the complete list with guidance on what warrants which level of response.

Fatigue that continues at the same intensity beyond four to six weeks on a stable dose, with no obvious cause, is worth raising with your prescriber rather than accepting as normal. It may reflect something unrelated to the medicine. The connection between semaglutide and persistent tiredness is something our clinical team reviews with patients when it comes up. Any suspected side effect can be reported directly to the MHRA through the Yellow Card scheme, it is open to patients, not just clinicians, and the data genuinely informs future safety decisions.

Starting Wegovy through a regulated service: what the process looks like

If you are weighing up whether to start treatment, tiredness is a reasonable thing to raise before you begin, not after. Our prescribers discuss side-effect likelihood, your starting health picture, and any factors that might make certain effects more or less likely, as part of the consultation, not as an add-on. That review happens the same day you submit your application; a real clinician reads it, not software.

Once approved, your medicine is dispatched from our GPhC-registered pharmacy through the licensed UK supply chain. It arrives with DPD the next working day in plain, unmarked packaging, the tracking notification lands on your phone before the box does. You can verify our pharmacy on the GPhC register (registration 9012878) in thirty seconds.

For anyone trying to get a sense of the wider treatment landscape before deciding, our treatment overview lays out what is licensed in the UK and what the consultation covers. If cost is part of the calculation, our page on Wegovy pricing in the UK gives an honest picture of how the market works, including what to be cautious about at the cheaper end.